Skip to main content
. 2022 Aug 10;13(4):e01423-22. doi: 10.1128/mbio.01423-22

TABLE 3.

Demographic and comorbidity data for the 77 volunteers

Sex and age group Total no. (%)a No. (% of all volunteers) with comorbidityb
AHT AR MD Obesity Insulin resistance COPD HT
Female
 All 41 (53.2) 11 (14.3) 8 (10.4) 1 (1.3) 6 (7.8) 6 (7.8) 3 (3.9) 7 (9.1)
 18–59 yrs 18 (23.4) 3 (3.9) 6 (7.8) 0 2 (2.6) 3 (3.9) 0 2 (2.6)
 ≥60 yrs 23 (30.0) 8 (10.4) 2 (2.6) 1 (1.3) 4 (5.2) 3 (3.9) 3 (3.9) 5 (6.5)
Male
 All 36 (46.8) 11 (14.3) 8 (10.4) 3 (3.9) 11 (14.3) 1 (1.3) 0 1 (1.3)
 18–59 yrs 17 (22.0) 4 (5.2) 4 (5.2) 2 (2.6) 4 (5.2) 0 0 0
 ≥60 yrs 19 (24.6) 7 (9.1) 4 (5.2) 1 (1.3) 7 (9.1) 1 (1.3) 0 1 (1.3)
a

Percentages are per all 77 volunteers with the characteristic.

b

AHT, arterial hypertension; COPD, chronic obstructive pulmonary disease; MD, mellitus diabetes; HT, hypothyroidism; AR, allergic rhinitis.